Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timolol eye drops for acute migraine
NCT02630719Terminated
- Sponsor
- University of Missouri-Kansas City
- Start
- Jan 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of timolol in migraine, sponsored by University of Missouri-Kansas City. Primary endpoint: Timolol Eye Drops in the Treatment of Acute Migraine Headache at 4 months. Started Jan 2016; status: terminated.
02
Drugs
timolol
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02630719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02630719.